IMS Health Holdings (IMS) Tops Q2 EPS by 2c

IMS Health Holdings (NYSE: IMS) reported Q2 EPS of $0.39, $0.02 better than the analyst estimate of $0.37. Revenue for the quarter came in at $662 million versus the consensus estimate of $654.92 million.

For earnings history and earnings-related data on IMS Health Holdings (IMS) click here.

You May Also Be Interested In

• JPMorgan Upgrades Aviva Plc (AV/:LN) (AIVAF) to Overweight
• JD.com earnings preview: stronger profit expected, macro headwinds in focus
• Morgan Stanley Upgrades Oil India Ltd. (OINL:IN) to Equalweight